Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants
Context. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver and decreasing insulin resistance in the skeletal mu...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2021/9979234 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556483043131392 |
|---|---|
| author | Aktham Mestareehi Xiangmin Zhang Berhane Seyoum Zaher Msallaty Abdullah Mallisho Kyle Jon Burghardt Anjaneyulu Kowluru Zhengping Yi |
| author_facet | Aktham Mestareehi Xiangmin Zhang Berhane Seyoum Zaher Msallaty Abdullah Mallisho Kyle Jon Burghardt Anjaneyulu Kowluru Zhengping Yi |
| author_sort | Aktham Mestareehi |
| collection | DOAJ |
| description | Context. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver and decreasing insulin resistance in the skeletal muscle. However, the molecular mechanism of metformin’s action in skeletal muscle is not well understood. Protein phosphatase 2A (PP2A), a major serine/threonine protein phosphatase, plays a pivotal role in cellular processes, such as signal transduction, cell proliferation, and apoptosis, and acts through dephosphorylating key signaling molecules such as AKT and AMPK. However, whether PP2A plays a role in metformin-induced insulin sensitivity improvement in human skeletal muscle cells remains to be elucidated. Objective. To investigate if PP2A plays a role in metformin-induced insulin sensitivity improvement in human skeletal muscle cells. Participants. Eight lean insulin-sensitive nondiabetic participants (4 females and 4 males; age: 21.0±1.0 years; BMI: 22.0±0.7 kg/m2; 2-hour OGTT: 97.0±6.0 mg/dl; HbA1c: 5.3±0.1%; fasting plasma glucose: 87.0±2.0 mg/dl; M value; 11.0±1.0 mg/kgBW/min). Design. A hyperinsulinemic-euglycemic clamp was performed to assess insulin sensitivity in human subjects, and skeletal muscle biopsy samples were obtained. Primary human skeletal muscle cells (shown to retain metabolic characteristics of donors) were cultured from these muscle biopsies that included 8 lean insulin-sensitive participants. Cultured cells were expanded, differentiated into myotubes, and treated with 50 μM metformin for 24 hours before harvesting. PP2Ac activity was measured by a phosphatase activity assay kit (Millipore) according to the manufacturer’s protocol. Results. The results indicated that metformin significantly increased the activity of PP2A in the myotubes for all 8 lean insulin-sensitive nondiabetic participants, and the average fold increase is 1.54±0.11 (P<0.001). Conclusions. These results provided the first evidence that metformin can activate PP2A in human skeletal muscle cells derived from lean healthy insulin-sensitive participants and may help to understand metformin’s action in skeletal muscle in humans. |
| format | Article |
| id | doaj-art-911aea2ca4744002ac182ccfe226cea7 |
| institution | Kabale University |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-911aea2ca4744002ac182ccfe226cea72025-02-03T05:45:19ZengWileyJournal of Diabetes Research2314-67452314-67532021-01-01202110.1155/2021/99792349979234Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy ParticipantsAktham Mestareehi0Xiangmin Zhang1Berhane Seyoum2Zaher Msallaty3Abdullah Mallisho4Kyle Jon Burghardt5Anjaneyulu Kowluru6Zhengping Yi7Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USADepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USADivision of Endocrinology, Wayne State University School of Medicine, Wayne State University, Detroit, MI 48201, USADivision of Endocrinology, Wayne State University School of Medicine, Wayne State University, Detroit, MI 48201, USADivision of Endocrinology, Wayne State University School of Medicine, Wayne State University, Detroit, MI 48201, USADepartment of Pharmacy Practice, Eugene Applebaum College of Pharmacy/Health Sciences, Wayne State University, Detroit, MI, USADepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USADepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48201, USAContext. Skeletal muscle insulin resistance is one of the primary contributors of type 2 diabetes (T2D). Metformin is the first-line drug for the treatment of T2D. The primary effects of metformin include decreasing glucose production in the liver and decreasing insulin resistance in the skeletal muscle. However, the molecular mechanism of metformin’s action in skeletal muscle is not well understood. Protein phosphatase 2A (PP2A), a major serine/threonine protein phosphatase, plays a pivotal role in cellular processes, such as signal transduction, cell proliferation, and apoptosis, and acts through dephosphorylating key signaling molecules such as AKT and AMPK. However, whether PP2A plays a role in metformin-induced insulin sensitivity improvement in human skeletal muscle cells remains to be elucidated. Objective. To investigate if PP2A plays a role in metformin-induced insulin sensitivity improvement in human skeletal muscle cells. Participants. Eight lean insulin-sensitive nondiabetic participants (4 females and 4 males; age: 21.0±1.0 years; BMI: 22.0±0.7 kg/m2; 2-hour OGTT: 97.0±6.0 mg/dl; HbA1c: 5.3±0.1%; fasting plasma glucose: 87.0±2.0 mg/dl; M value; 11.0±1.0 mg/kgBW/min). Design. A hyperinsulinemic-euglycemic clamp was performed to assess insulin sensitivity in human subjects, and skeletal muscle biopsy samples were obtained. Primary human skeletal muscle cells (shown to retain metabolic characteristics of donors) were cultured from these muscle biopsies that included 8 lean insulin-sensitive participants. Cultured cells were expanded, differentiated into myotubes, and treated with 50 μM metformin for 24 hours before harvesting. PP2Ac activity was measured by a phosphatase activity assay kit (Millipore) according to the manufacturer’s protocol. Results. The results indicated that metformin significantly increased the activity of PP2A in the myotubes for all 8 lean insulin-sensitive nondiabetic participants, and the average fold increase is 1.54±0.11 (P<0.001). Conclusions. These results provided the first evidence that metformin can activate PP2A in human skeletal muscle cells derived from lean healthy insulin-sensitive participants and may help to understand metformin’s action in skeletal muscle in humans.http://dx.doi.org/10.1155/2021/9979234 |
| spellingShingle | Aktham Mestareehi Xiangmin Zhang Berhane Seyoum Zaher Msallaty Abdullah Mallisho Kyle Jon Burghardt Anjaneyulu Kowluru Zhengping Yi Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants Journal of Diabetes Research |
| title | Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants |
| title_full | Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants |
| title_fullStr | Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants |
| title_full_unstemmed | Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants |
| title_short | Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants |
| title_sort | metformin increases protein phosphatase 2a activity in primary human skeletal muscle cells derived from lean healthy participants |
| url | http://dx.doi.org/10.1155/2021/9979234 |
| work_keys_str_mv | AT akthammestareehi metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT xiangminzhang metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT berhaneseyoum metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT zahermsallaty metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT abdullahmallisho metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT kylejonburghardt metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT anjaneyulukowluru metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants AT zhengpingyi metforminincreasesproteinphosphatase2aactivityinprimaryhumanskeletalmusclecellsderivedfromleanhealthyparticipants |